| Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
| Tel: |
13636370518 |
| Email: |
shyysw007@163.com |
| Products Intro: |
Product Name:1H-Indole-2-carboxamide, 5-chloro-N-((1S)-1-((4-fluorophenyl)methyl)-2-(4-hydroxy-1-piperidinyl)-2-oxoethyl)-
CAS:186430-23-9
Package:50mg;100mg Remarks:V37868
|
CP-320626 manufacturers
- CP-320626
-
- $912.00
-
2026-08-08
- CAS:186430-23-9
- Purity: 98.06%
- Supply Ability: 10g
|
| | CP-320626 Basic information |
| Product Name: | CP-320626 | | Synonyms: | CP-320626;1H-Indole-2-carboxamide, 5-chloro-N-[(1S)-1-[(4-fluorophenyl)methyl]-2-(4-hydroxy-1-piperidinyl)-2-oxoethyl]- | | CAS: | 186430-23-9 | | MF: | C23H23ClFN3O3 | | MW: | 443.9 | | EINECS: | | | Product Categories: | | | Mol File: | 186430-23-9.mol |  |
| | CP-320626 Chemical Properties |
| Boiling point | 770.8±60.0 °C(Predicted) | | density | 1.401±0.06 g/cm3(Predicted) | | pka | 14.06±0.46(Predicted) |
| | CP-320626 Usage And Synthesis |
| Uses | CP320626 is a potent inhibitor of human liver glycogen phosphorylase (IC50=205 nM). CP320626 reduces blood glucose in diabetic mice without changing plasma insulin levels. CP320626 can be used in the study of type 2 diabetes[1]. | | References | [1] Oikonomakos, et al. A new allosteric site in glycogen phosphorylase b as a target for drug interactions. Structure 8.6 (2000): 575-584. DOI:10.1016/s0969-2126(00)00144-1 |
| | CP-320626 Preparation Products And Raw materials |
|